Skip to main content

Lupus (Systemic Lupus Erythematosus) and cannabis in Massachusetts

The state does not list this condition by name, but its statute or regulator permits a certifying physician to add conditions case-by-case. Patients should expect to bring full diagnostic records to the certification visit.

Physician-discretion program
✗ No
LEGAL
10 oz usable (60-day su…
POSSESSION
$50/yr
STATE FEE
7–21 d
TIMELINE
Physician-discretion program. The state does not list this condition by name, but its statute or regulator permits a certifying physician to add conditions case-by-case. Patients should expect to bring full diagnostic records to the certification visit.

Massachusetts statute and program

The Massachusetts Medical Use of Marijuana Program is the operating authority for Massachusetts patient certification. The authoritative legal text is: M.G.L. Chapter 94G: Regulation of the Use and Distribution of Marijuana Not Medically Prescribed. The program portal is at Massachusetts Medical Use of Marijuana Program.

What the evidence says about cannabis and Lupus (Systemic Lupus Erythematosus)

Systemic lupus erythematosus (SLE), commonly called lupus, is a chronic autoimmune disease in which the immune system produces autoantibodies that attack the body's own tissues. Inflammation can affect joints, skin, kidneys, blood, lungs, heart, and the nervous system. Lupus is a relapsing-remitting disease — patients experience flares and periods of relative quiescence.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Lupus (Systemic Lupus Erythematosus) page.

How to qualify in Massachusetts

The Massachusetts Medical Use of Marijuana Program requires the following registration steps for a Lupus (Systemic Lupus Erythematosus) patient (or any qualifying diagnosis):

  1. Get certified by a Massachusetts-licensed certifying healthcare provider. A Massachusetts-licensed physician, certified nurse practitioner, or physician assistant registered with the Cannabis Control Commission (CCC) Medical Use of Marijuana Program must establish a bona-fide provider-patient relationship and certify a debilitating condition. CCC regulations allow providers to certify enumerated conditions (cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Crohn’s, Parkinson’s, MS) plus "other conditions determined by a qualifying provider" — broad practitioner discretion.
  2. Complete the online patient registration via Virtual Gateway. After certification, the provider creates a Virtual Gateway PIN that the patient uses to complete the online registration through the Massachusetts Cannabis Control Commission MMJ Online System. Patients upload a Massachusetts driver license or state ID and a passport-style photo.
  3. Pay the $50 state fee (or qualify for fee waiver). The annual program registration fee is $50, waived for veterans, low-income patients (verified through MassHealth, SNAP, SSI, SSDI, or Veterans Affairs benefits documentation), and hospice patients. Temporary patient registration cards are emailed within several business days of approval; physical cards arrive within roughly two to three weeks.
  4. Purchase from a Massachusetts medical marijuana treatment center. With the temporary or physical card, patients may purchase up to a 60-day supply (default 10 ounces) from any of the licensed Massachusetts Medical Marijuana Treatment Centers. Adult-use retail exists statewide for adults 21+, but the medical registration provides access to medical-only products, no excise tax, higher possession limits, and family-court and workplace protections under M.G.L. c. 94I.
State registration fee
$50
Physician visit (typical)
$150–$300
Certification to card
7–21 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full Massachusetts registration steps, fees, and reciprocity rules, see the Massachusetts cannabis-laws page.

ICD-10 code

A certifying physician documenting Lupus (Systemic Lupus Erythematosus) for the Massachusetts medical cannabis program will typically record ICD-10 M32.9 or SNOMED-CT 55464009 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Massachusetts list Lupus (Systemic Lupus Erythematosus) as a qualifying condition for medical cannabis?

Not by name, but Massachusetts permits physician discretion. Under Massachusetts Medical Use of Marijuana Program, a certifying physician can add a condition like Lupus (Systemic Lupus Erythematosus) on a case-by-case basis when the physician judges that the patient would benefit from medical cannabis. This is different from a state where the qualifying-condition list is fixed in statute. Whether a particular physician will certify Lupus (Systemic Lupus Erythematosus) depends on the physician's training, the strength of the patient's documentation, and the practitioner's reading of the available evidence — evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). Patients should expect to bring full diagnostic records to the certification visit.

How do I get a Massachusetts medical marijuana card for Lupus (Systemic Lupus Erythematosus)?

Step one is finding a physician licensed in Massachusetts who is registered with Massachusetts Medical Use of Marijuana Program and willing to evaluate Lupus (Systemic Lupus Erythematosus) cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Massachusetts does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. The authoritative source for the current process is the Massachusetts Medical Use of Marijuana Program site at https://masscannabiscontrol.com/medical-use/; the state updates fees, forms, and physician registration rules periodically.

What does the evidence say about cannabis for Lupus (Systemic Lupus Erythematosus)?

For Lupus (Systemic Lupus Erythematosus), evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Lupus (Systemic Lupus Erythematosus) lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Lupus (Systemic Lupus Erythematosus) should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Lupus (Systemic Lupus Erythematosus) and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Lupus (Systemic Lupus Erythematosus); the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. M.G.L. Chapter 94G: Regulation of the Use and Distribution of Marijuana Not Medically Prescribedaccessed May 16, 2026
  2. M.G.L. Chapter 94I: Medical Use of Marijuanaaccessed May 16, 2026
  3. Massachusetts Cannabis Control Commissionaccessed May 16, 2026
  4. Question 4 of 2016: Regulation and Taxation of Marijuana Act (Ballotpedia)accessed May 16, 2026
  5. NORML: Massachusetts Laws & Penaltiesaccessed May 16, 2026
  6. NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases: Lupusaccessed May 18, 2026
  7. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 18, 2026

    “Substantial evidence that cannabis or cannabinoids are effective for chronic pain in adults.”

  8. Lupus Foundation of America: Marijuana and Lupusaccessed May 18, 2026
  9. American College of Rheumatology: 2023 Guideline for SLE Management (executive summary)accessed May 18, 2026
  10. MedlinePlus: Systemic lupus erythematosusaccessed May 18, 2026